|
KMID : 1195620210140010050
|
|
Clinical and Experimental Otorhinolaryngology
2021 Volume.14 No. 1 p.50 ~ p.60
|
|
|
Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
|
|
Uz Uzdan
Eskiizmir Gorkem
|
|
|
Abstract
|
|
|
|
Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have reported that IL-6 targeted therapies might provide significant benefits for cancer treatment. The purpose of this systematic review is to evaluate IL-6 activity in patients with head and neck squamous cell carcinoma (HNSCC). A systematic review of the association between serum, saliva and tumor IL-6 and HNSCC was developed on PubMed/Medline in the publication range from January 1995 to January 2019. Our literature analysis demonstrated that overexpression and elevated serum and/or saliva IL-6 concentrations in patients with HNSCC are related to poor survival and oncological outcomes. Although there is a correlation between IL-6 concentrations and tumorigenicity, it is noteworthy that IL-6 targeted therapies are generally performed in vitro and in experimental studies. Therefore, prospective, randomized clinical trials are required that focus on IL-6 targeted therapies for the treatment of HNSCC.
|
|
|
KEYWORD
|
|
|
Interleukin 6, Survival, Carcinogenesis, Inflammation, Head and Neck Neoplasms
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|